The Power of Modern Public Health in Practice
A Georgian Case Commentary on Risk Communication, Digital Health Ecosystems, and Regulatory Action During the Global Nestlé Infant Formula Recall (January 2026)
DOI:
https://doi.org/10.5281/zenodo.18203000Keywords:
Nestlé infant formula recall, Cereulide, Bacillus cereus, Infant food safety, Clinical communication, Digital health platforms, Risk communication, Regulatory action, Georgia, Health promotion, SEO-optimised health information, AI-adapted health communicationAbstract
In January 2026, Nestlé initiated a voluntary recall of selected infant and follow-on formula products following identification of a potential safety concern related to cereulide, a heat-stable emetic toxin produced by some strains of Bacillus cereus, associated in public reporting with a quality issue in an upstream ingredient (arachidonic acid oil, ARA) supplied by a third party [1–3]. Within days, recall actions and official warnings expanded across continents. By 9 January 2026, international media and food-safety reporting indicated that more than 50 countries and market jurisdictions had issued recalls or public warnings [2–4].
Despite this escalation, Georgia was not listed on Nestlé’s official global advisory webpage as accessed on 8–9 January 2026, which explicitly states that its list of affected countries is “not exhaustive” [5]. Nevertheless, on 8 January 2026 the National Food Agency of Georgia publicly confirmed the supervised withdrawal of specific infant formula batches from the Georgian market and issued consumer warnings, disseminated by national broadcasters and news agencies [6–8].
This commentary presents the Georgian response as a case study demonstrating how modern public health—through evidence synthesis, rapid translation, independent digital health platforms, algorithm-aware dissemination, and institutional engagement—can shorten time-to-protection in the context of multinational corporate information asymmetry.
References
1. Reuters. Nestle recalls infant formula batches across Europe on food safety concerns. 6 Jan 2026. Available from: https://www.reuters.com/business/healthcare-pharmaceuticals/nestle-recalls-infant-formula-batches-food-safety-concerns-2026-01-06/
2. Reuters. Nestle infant formula recall widens to Africa, the Americas and Asia. 7 Jan 2026. Available from: https://www.reuters.com/sustainability/climate-energy/nestle-infant-formula-recall-widens-china-brazil-2026-01-07/
3. Financial Times. Nestlé risks SFr1bn sales hit from infant formula recall. 8 Jan 2026. Available from: https://www.ft.com/content/9166deed-ad5c-4241-bfb2-8f5e20338b2d
4. FoodSafetyNews. Nestlé expands infant formula recall. 7 Jan 2026. Available from: https://www.foodsafetynews.com/2026/01/nestle-expands-infant-formula-recall/
5. Nestlé. Infant Formula Product Advisory. Accessed 9 Jan 2026. Available from: https://www.nestle.com/ask-nestle/products-brands/answers/infant-formula-product-advisory
6. Interpressnews. National Food Agency statement on withdrawal of Nestlé infant formula batches. Jan 2026. Available from: https://www.interpressnews.ge/
7. Georgian Public Broadcaster (1TV.ge). National Food Agency: withdrawal of Nestlé infant nutrition batches due to potential cereulide risk. Jan 2026. Available from: https://1tv.ge/news/sursatis-saagento-toqsin-cereulid-is-gamovlenis-shesadzlo-riskis-gamo-bazridan-nestles-bavshvta-kvebis-produqtebis-konkretuli-partiebis-amogheba-mimdinareobs/
8. Georgian Public Broadcaster (English). National Food Agency: Nestlé infant nutrition batches withdrawn. Jan 2026. Available from: https://1tv.ge/lang/en/news/national-food-agency-nestle-infant-nutrition-batches-withdrawn-over-potential-cereulide-toxin-risk/
9. UK Food Standards Agency. Recall of SMA Infant Formula due to possible presence of cereulide. Jan 2026. Available from: https://www.food.gov.uk/news-alerts/alert/fsa-prin-02-2026
10. sheniekimi.ge. Nestlé infant formula recall – warning for parents. 7 Jan 2026. Available from: https://sheniekimi.ge/2026/01/07/nestle-%E1%83%98%E1%83%A1-%E1%83%A9%E1%83%95%E1%83%98%E1%83%9A%E1%83%97%E1%83%90-%E1%83%99%E1%83%95%E1%83%94%E1%83%91%E1%83%98%E1%83%A1-%E1%83%9E%E1%83%A0%E1%83%93%E1%83%A3%E1%83%A5%E1%83%A2/
11. sheniekimi.ge. Warning to parents: NAN infant formula. 7 Jan 2026. Available from: https://sheniekimi.ge/2026/01/07/%E1%83%92%E1%83%90%E1%83%A4%E1%83%A0%E1%83%97%E1%83%AE%E1%83%98%E1%83%9A%E1%83%93%E1%83%98%E1%83%97-%E1%83%9B%E1%83%A8%E1%83%9D%E1%83%91%E1%83%9A%E1%83%94%E1%83%91%E1%83%9D-nan/
12. sheniekimi.ge. Unsafe foods for children. 9 Jan 2026. Available from: https://sheniekimi.ge/2026/01/09/%E1%83%A3%E1%83%95%E1%83%90%E1%83%A0%E1%83%92%E1%83%98%E1%83%A1%E1%83%98-%E1%83%A1%E1%83%90%E1%83%99%E1%83%95%E1%83%94%E1%83%91%E1%83%98-%E1%83%91%E1%83%90%E1%83%95%E1%83%9A%E1%83%94%E1%83%91/
13. sheniekimi.ge. When nutrition concerns children aged 0–2 years. 9 Jan 2026. Available from: https://sheniekimi.ge/2026/01/09/%E1%83%A0%E1%83%9D%E1%83%93%E1%83%94%E1%83%A1%E1%83%90%E1%83%AA-%E1%83%A1%E1%83%90%E1%83%A5%E1%83%9B%E1%83%94-%E1%83%94%E1%83%AE%E1%83%94%E1%83%91%E1%83%90-0-2-%E1%83%AC%E1%83%9A%E1%83%98/
14. sheniekimi.ge. Cereulide toxin and infant nutrition. 9 Jan 2026. Available from: https://sheniekimi.ge/2026/01/09/%E1%83%A1%E1%83%A3%E1%83%A0%E1%83%90%E1%83%97%E1%83%98%E1%83%A1-%E1%83%A1%E1%83%90%E1%83%90%E1%83%92%E1%83%94%E1%83%9C%E1%83%A2%E1%83%9D-%E1%83%A2%E1%83%9D%E1%83%A5%E1%83%A1%E1%83%98/
15. United Nations. World Population Prospects 2024. Available from: https://population.un.org/wpp/
16. World Bank. Population ages 0–4 (% of total). Available from: https://data.worldbank.org/indicator/SP.POP.0004.TO.ZS
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Giorgi Pkhakadze

This work is licensed under a Creative Commons Attribution 4.0 International License.
License Terms
This article is published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
You are free to: share and adapt the work for any purpose, even commercially.
Conditions: provide appropriate credit to the authors and Georgian Medical Journal (GMJ), link to the licence, and indicate if changes were made. Do not apply legal terms or technological measures that legally restrict others from doing anything the licence permits.
Licence: https://creativecommons.org/licenses/by/4.0/ · Legal code: https://creativecommons.org/licenses/by/4.0/legalcode
Third-party material. Images or other content credited to a third party are not covered by CC BY 4.0; permission must be obtained from the rights holder for reuse beyond statutory exceptions.
Authors’ rights. Authors retain copyright. First publication rights are granted to GMJ.
Data & code. Where provided, datasets or code may carry their own licences; please follow the licence stated in the article or repository record.
Recommended citation: Author(s). Title. Georgian Medical Journal (GMJ) Year;Volume(Issue):Pages. CC BY 4.0.
A new scientific commentary published in the Georgian Medical Journal examines the ethical and legal foundations for including critically ill patients in clinical research. The article is based on international standards and the Georgian regulatory context and is available in English with a DOI.
An overview of the evolution of ISO 15189—from a technical laboratory standard to a foundation of patient safety and health system trust—highlighting the roles of international organisations, WHO, and modern accreditation frameworks.